The multinational Bayer owns Monsanto and the herbicide Roundup.
For Ron Miller, Bayer made bad choices in this matter. The fact that they did not seek further amicable settlement is a mystery.
The group has reaffirmed its intention to go to trial whenever it is attacked over the alleged effects of Roundup.
He emphasized that he had won his case in several recent proceedings related to Roundup, based on evaluations by regulators and scientists who continue to consider this product safe.
< p class="StyledBodyHtmlParagraph-sc-48221190-4 hnvfyV">In mid-November, a Missouri court jury fined Monsanto $1.5 billion in damages and interests for the benefit of three Americans who had also attributed their non-Hodgkin lymphoma to years of use of Roundup.
The group also appealed this conviction.
According to Bayer, 113,000 of the approximately 165,000 lawsuits against Monsanto related to the herbicide have been resolved or declared inadmissible to date.
In June 2020, the pharmaceutical and biotechnology giant reached an out-of-court settlement covering, according to the company, approximately 75% of the 125,000 shares then outstanding.
The transaction provided for the payment of a total sum of between 10.1 and 10.9 billion US dollars.
Bayer also spent $400 million to compensate people exposed to another herbicide, dicamba , and 820 million for disputes linked to PCBs (polychlorinated biphenyls), so-called eternal pollutants.
In 2021, the& #x27;company allocated an additional US$4.5 billion to manage these procedures, bringing the total envelope to more than $16 billion.